Skip to main content

Table 5 The associations between IL-13 promoter haplotypes and SMA

From: Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and -4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels

Haplotypes

Odds Ratio

95% CI

P value

-7402G/-4729G, (n = 53)

1.211

0.663-2.212

0.533

-7402 T/-4729A, (n = 181)

1.564

1.023-2.389

0.039

-7402 T/-4729G, (n = 311)

0.760

0.449-1.286

0.307

  1. Multivariate logistic regression analyses were used to determine the odds ratio (OR) and 95% CI, controlling for age, gender, G6PD deficiency, sickle-cell trait status and presence of bacterial infections [10, 13, 36–38]. The haplotype non-carriers were used as reference groups for the analyses in the regression analyses.
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us